Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-022154
Filing Date
2025-05-05
Accepted
2025-05-05 16:05:23
Documents
87
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q twst-20250331.htm   iXBRL 10-Q 1180651
2 EX-31.1 twst-2025331x10qxex311.htm EX-31.1 10604
3 EX-31.2 twst-2025331x10qxex312.htm EX-31.2 10409
4 EX-32.1 twst-2025331x10qxex321.htm EX-32.1 4871
5 EX-32.2 twst-2025331x10qxex322.htm EX-32.2 4568
11 10-Q twst-20250331_g1.jpg GRAPHIC 1195
  Complete submission text file 0001628280-25-022154.txt   6605072

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT twst-20250331.xsd EX-101.SCH 44005
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT twst-20250331_cal.xml EX-101.CAL 66857
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT twst-20250331_def.xml EX-101.DEF 149091
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT twst-20250331_lab.xml EX-101.LAB 589131
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT twst-20250331_pre.xml EX-101.PRE 399676
89 EXTRACTED XBRL INSTANCE DOCUMENT twst-20250331_htm.xml XML 971197
Mailing Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 800-719-0671
Twist Bioscience Corp (Filer) CIK: 0001581280 (see all company filings)

EIN.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38720 | Film No.: 25912874
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)